Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-22-045329)

Filing Details

Accession Number:: 0001209191-22-045329
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2022-08-10 20:43:27
Reporting Period:: 2022-08-08

Accepted Time:: 2022-08-10 20:43:27
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1029142	Dynavax Technologies Corp	DVAX	Pharmaceutical Preparations (2834)	330728374

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1777938	Ryan Spencer	C/O Dynavax Technologies 2100 Powell Street, Suite 900 Emeryville CA 94608	Ceo And Director	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2022-08-08	29,663	$0.00	159,434	No	4	M	Direct
Common Stock	Disposition	2022-08-09	14,921	$16.92	144,513	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Restricted Stock Unit	Acquisiton	2022-08-08	29,663	$0.00	29,663	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
9,887		2022-12-31	No	4	M	Direct

Footnotes

Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of common stock. These RSUs vested upon the Issuer's achievement of a certain performance condition.
Not applicable
The reporting person is reporting the sale of 14,921 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the delivery of common stock to the reporting person on August 8, 2022.